RxDoctor Payments Data

Elizabeth Wood, PA

Physician Assistant · Monticello, GANPI 1356659825

Payments from drug & device makers

$1,697in general payments, 2019–2025

Across 83 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$207
  • E.r. Squibb & Sons, L.L.C.$187
  • AbbVie$168
  • Otsuka America Pharmaceutical, Inc.$144
  • Lilly USA, LLC$97
  • Corcept Therapeutics$90
  • plus $805 from 19 others

What the payments were for

  • Food & beverage$1,697100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,697 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$26,664
Medicare patients
95
Services billed
357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SprycelDasatinib12$75,357
EliquisApixaban79$48,878
OzempicSemaglutide15$28,949
JardianceEmpagliflozin24$28,639
GemtesaVibegron107$25,508
GlatopaGlatiramer Acetate12$20,058
MounjaroTirzepatide15$15,373
XareltoRivaroxaban28$13,855
EntrestoSacubitril/Valsartan14$9,204
BrilintaTicagrelor13$7,304
MresviaRsv Vaccine, Pref, Mrna/Pf23$7,008
NamzaricMemantine Hcl/Donepezil Hcl12$6,969
JanuviaSitagliptin Phosphate12$6,434
FarxigaDapagliflozin Propanediol11$6,266
KerendiaFinerenone13$4,546

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
E.r. Squibb & Sons, L.L.C.Sprycel$187$75,35712 claims
PfizerEliquis$34$48,87879 claims
Novo NordiskOzempic, Novolog$21$29,90027 claims
Boehringer IngelheimJardiance$81$28,63924 claims
Lilly USA, LLCMounjaro$97$15,37315 claims
Johnson & JohnsonXarelto$79$13,85528 claims
AstraZenecaBrilinta, Farxiga$207$13,57124 claims
AbbVieNamzaric$168$6,96912 claims
MerckJanuvia$75$6,43412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Monticello

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →